Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -34.04% is 57% above its 5-year average of -78.78%, near the high end of its 5-year range (-331.91%–25.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 75.39% above its 12-month average of -138.30%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -34.04%.
RETURN ON EQUITY (ROE)
-34.04%
RETURN ON EQUITY (ROE) AVG TTM
-138.30%
RETURN ON EQUITY (ROE) AVG 3Y
-66.90%
RETURN ON EQUITY (ROE) AVG 5Y
-78.78%
RETURN ON EQUITY (ROE) AVG 10Y
-56.23%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.39%
CURRENT VS 3Y AVG
+49.13%
CURRENT VS 5Y AVG
+56.80%
CURRENT VS 10Y AVG
+39.47%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 628 covered companies
CURRENT VS SECTOR MEDIAN
+15.35%
vs the sector median at left
MacroGenics, Inc.
Market Cap
$236.14M
Return on Equity (ROE)
-34.04%
TTM Avg
-138.30%
3Y Avg
-66.90%
5Y Avg
-78.78%
Market Cap
$235.37M
Return on Equity (ROE)
-25.20%
TTM Avg
-25.82%
3Y Avg
5.12%
5Y Avg
5.12%
Market Cap
$236.81M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$240.09M
Return on Equity (ROE)
-27.27%
TTM Avg
-92.43%
3Y Avg
-64.95%
5Y Avg
-57.80%
Market Cap
$240.31M
Return on Equity (ROE)
-118.58%
TTM Avg
62.37%
3Y Avg
-376.78%
5Y Avg
-340.60%
Market Cap
$231.88M
Return on Equity (ROE)
-303.61%
TTM Avg
612.49%
3Y Avg
-57.80%
5Y Avg
-87.69%
Market Cap
$239.40M
Return on Equity (ROE)
N/A
TTM Avg
-125.28%
3Y Avg
-42.20%
5Y Avg
-43.41%
Market Cap
$229.29M
Return on Equity (ROE)
-65.59%
TTM Avg
-45.72%
3Y Avg
-59.51%
5Y Avg
-49.73%
Market Cap
$243.34M
Return on Equity (ROE)
N/A
TTM Avg
35.05%
3Y Avg
64.68%
5Y Avg
-167.54%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $236.14M | -34.04% | -138.30% | -66.90% | -78.78% |
| BioAge Labs Inc. (BIOA)vs › | $235.37M | -25.20% | -25.82% | 5.12% | 5.12% |
| High Tide Inc. (HITI)vs › | $236.81M | -31.55% | -30.05% | -33.97% | -37.95% |
| InflaRx N.V. (IFRX)vs › | $240.09M | -27.27% | -92.43% | -64.95% | -57.80% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.31M | -118.58% | 62.37% | -376.78% | -340.60% |
| Biodesix, Inc. (BDSX)vs › | $231.88M | -303.61% | 612.49% | -57.80% | -87.69% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.40M | N/A | -125.28% | -42.20% | -43.41% |
| Profound Medical Corp. (PROF)vs › | $229.29M | -65.59% | -45.72% | -59.51% | -49.73% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | N/A | 35.05% | 64.68% | -167.54% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.83M | -695.56% | -3698.55% | -1897.26% | -1268.80% |
ROE
-34.0%
ROA
-4.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -34.04% |
| 2026-03-31 | -331.91% |
| 2025-12-31 | -134.23% |
| 2025-09-30 | -113.26% |
| 2025-06-30 | -78.08% |
| 2025-03-31 | -70.54% |
| 2024-12-31 | -57.70% |
| 2024-09-30 | -81.30% |
| 2024-06-30 | -235.86% |
| 2024-03-31 | -21.89% |
| 2023-12-31 | -5.94% |
| 2023-09-30 | 25.68% |
| 2023-06-30 | 4.34% |
| 2023-03-31 | -83.58% |
| 2022-12-31 | -84.19% |
| 2022-09-30 | -154.84% |
| 2022-06-30 | -153.33% |
| 2022-03-31 | -121.81% |
| 2021-12-31 | -84.35% |
| 2021-09-30 | -50.16% |
| 2021-06-30 | -40.54% |
| 2021-03-31 | -38.88% |
| 2020-12-31 | -43.85% |
| 2020-09-30 | -54.20% |
| 2020-06-30 | -67.25% |
| 2020-03-31 | -79.51% |
| 2019-12-31 | -65.83% |
| 2019-09-30 | -65.07% |
| 2019-06-30 | -52.80% |
| 2019-03-31 | -52.07% |
| 2018-12-31 | -70.59% |
| 2018-09-30 | -7.46% |
| 2018-06-30 | -10.93% |
| 2018-03-31 | -12.74% |
| 2017-12-31 | -6.56% |
| 2017-09-30 | -84.52% |
| 2017-06-30 | -63.51% |
| 2017-03-31 | -28.05% |
| 2016-12-31 | -21.78% |
| 2016-09-30 | -17.39% |
| 2016-06-30 | -10.24% |
| 2016-03-31 | -33.41% |
| 2015-12-31 | -6.43% |
| 2015-09-30 | -3.16% |
| 2015-06-30 | 0.38% |
| 2015-03-31 | 4.30% |
| 2014-12-31 | -31.59% |
| 2014-09-30 | -16.18% |
| 2014-06-30 | -8.43% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -0.33% |
